Renowned Electrophysiologist Appointed Chief of Cardiovascular Division
Jeffrey J. Goldberger, M.D., M.B.A., has been named Chief of the Cardiovascular Division at the University of Miami Miller School of Medicine, adding to the Division’s already stellar faculty. He will also oversee all cardiac clinical care at UHealth – the University of Miami Health System. A renowned electrophysiologist who has published nearly 200 studies, Goldberger joins the Miller School this week from Northwestern University Feinberg School of Medicine, where he was professor of medicine and Director of the Program in Cardiac Arrhythmias in the Center for Cardiovascular Innovation.
“We are extremely invigorated to have Dr. Goldberger joining the Miller School of Medicine, bringing his commitment to breakthrough research and innovative clinical care to South Florida,” said Roy E. Weiss, M.D., Ph.D., professor and Chairman of Medicine at the Miller School. “He shares our commitment to translating research into personalized clinical care.”
Goldberger plans to expand the multidisciplinary team approach to detecting, diagnosing, and successfully treating atrial fibrillation, developing novel ablation procedures to treat arrhythmias in patients at UHealth.
“With the excellent clinical structure UHealth has established in the region, there is a rich environment for innovation and discovery,” said Goldberger, who will be professor of medicine at the Miller School. He will also integrate cardiology services performed by UHealth doctors at Jackson Memorial Hospital and the Miami VA Healthcare System.
“We have a unique opportunity to leverage our expertise in electrophysiology, interventional cardiology, advanced heart failure, vascular treatments and imaging to offer patients multidisciplinary therapies,” Goldberger said. “I hope to accelerate the pace of discoveries and enhance our translational research to open new opportunities to bring the discoveries to the patients who need them.”
With continuous funding from the National Institutes of Health and the American Heart Association over the last 12 years, Goldberger has a history of leading novel trials that shift the standard of care. Most recently, he led the OBTAIN (Outcomes of Beta-Blocker Therapy After Myocardial Infarction) study, which found that heart attack patients treated with a substantially lower dosage of beta-blockers than used in earlier trials survived at the same rate, or even better, than those receiving higher doses. The study was published in the September 21, 2015, Journal of the American College of Cardiology.
Goldberger leads a national think tank on sudden cardiac death, continuing the decade-long work he has done with Robert Myerburg, M.D., professor of medicine at the Miller School and a renowned expert in the field.
After receiving his medical degree and completing his residency at Albert Einstein College of Medicine, Goldberger completed a fellowship in cardiology at the University of California, San Francisco. He has served as an editorial consultant on nearly two dozen professional or peer-reviewed journals, including the Journal of the American Medical Association, Circulation and the New England Journal of Medicine.
Goldberger’s wife, Sharon Sholiton, M.D., is Associate Dean for Student Affairs at Rush University Medical School in Chicago, and they have four children.